3M's health care spinoff will be known as Solventum, the company announced Thursday.
The Maplewood-based manufacturer intends to complete the separation of the $8.4 billion business in the first half of 2024 after initially aiming for the end of this year.
"We have appointed the leadership team in there, and the teams are making very good progress in driving to the spin date," 3M President and Chief Financial Officer Monish Patolawala said earlier this month at an investor conference.
In August, 3M hired Bryan Hanson, the head of Zimmer Biomet, as CEO of the health care group. Carrie Cox will be executive chair, and former Insulet executive Wayde McMillan will be chief financial officer, the company announced last month.
Solventum will remain headquartered in Minnesota for at least a "transitional" period after the separation. The spinoff was first announced in July 2022.
"This is another significant milestone on the path to building two-world class companies, 3M and Solventum," 3M CEO Mike Roman said in a statement.
The Solventum name is meant as a combination of the words "solving" and "momentum."
"It started with employees — we did a lot of listening sessions where they identified themselves as problem solvers," Danette Andley, chief marketing officer for 3M health care, said in an interview. "With customers, this name tested higher than any other."